|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
ZS Pharma, Inc.
| | | Phone: | (650) 458-4100 | Fax: | (650) 458-0084 | Year Established: | 2008 | Main Contact: | Cynthia Smith, MS, MBA, CCO | | Other Contacts: | Jose A. Menoyo, M.D., Senior VP of Medical Affairs Megan A. Clifford, Executive Director of Marketing Stewart A. Turner, Ph.D., Executive Director of Medical Affairs Mark Asbury, Senior VP & General Counsel Adam L. Tomasi, Ph.D., Senior VP, Corporate Development Henrik Sandvad Rasmussen, M.D., Ph.D., CMO & CSO D. Jeffrey Keyser, RPh, J.D., MPA, Ph.D., COO Alvaro Guillem, Ph.D., President Robert Alexander, Ph.D., Chairman & CEO
| | Company Description | ZS Pharma, part of the AstraZeneca Group, is a specialty pharmaceutical company. ZS Pharma’s lead therapeutic candidate, ZS-9, is in Phase 3 clinical trials. It is being developed to treat hyperkalemia, a potentially life-threatening metabolic condition characterized by an abnormally high serum concentration of potassium. ZS Pharma is also pursuing the discovery of additional drug candidates that utilize its novel selective ion-trap technology for the treatment of kidney and liver diseases. | |
|
|
|
|
|